cusip,prc,openprc,date,htick,hcomnam,hsiccd,numshr
30233G20,0.894,0.94,2009-01-02,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,0.88,0.85,2009-01-05,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,0.89,0.89,2009-01-06,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,0.86,0.87,2009-01-07,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,0.89,0.89,2009-01-08,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,0.87,0.99,2009-01-09,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,0.9901,0.99,2009-01-12,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,0.99,0.9,2009-01-13,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,0.9899,0.99,2009-01-14,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,-0.945,,2009-01-15,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,0.99,1.0,2009-01-16,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.11,0.91,2009-01-20,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.1,0.88,2009-01-21,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.08,0.941,2009-01-22,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.04,1.02,2009-01-23,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.05,1.0,2009-01-26,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.0401,1.0001,2009-01-27,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.06,1.0601,2009-01-28,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,0.936,1.05,2009-01-29,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,-0.915,,2009-01-30,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,0.85,0.86,2009-02-02,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,0.94,0.96,2009-02-03,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,0.78,0.85,2009-02-04,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,0.8199,0.79,2009-02-05,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,0.75,0.8,2009-02-06,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,0.852,0.77,2009-02-09,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,0.83,0.87,2009-02-10,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,0.76,0.76,2009-02-11,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,0.75,0.77,2009-02-12,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,0.75,0.76,2009-02-13,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,0.75,0.71,2009-02-17,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,0.7001,0.71,2009-02-18,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,-0.77,,2009-02-19,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,0.73,0.8,2009-02-20,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,0.8,0.73,2009-02-23,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,0.8,0.77,2009-02-24,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,-0.755,,2009-02-25,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,-0.76,,2009-02-26,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,0.65,0.65,2009-02-27,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,0.651,0.65,2009-03-02,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,0.646,0.66,2009-03-03,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,0.6599,0.66,2009-03-04,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,0.66,0.65,2009-03-05,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,0.64,0.601,2009-03-06,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,0.606,0.66,2009-03-09,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,0.8,0.66,2009-03-10,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,0.6201,0.79,2009-03-11,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,0.75,0.78,2009-03-12,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,0.7799,0.78,2009-03-13,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,0.78,0.7,2009-03-16,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,-0.79,,2009-03-17,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,0.8199,0.8,2009-03-18,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,0.8,0.6,2009-03-19,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,0.8,0.82,2009-03-20,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,0.8,0.8101,2009-03-23,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,0.87,0.85,2009-03-24,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,0.9,0.87,2009-03-25,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.0001,0.9,2009-03-26,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.0001,1.0,2009-03-27,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.05,1.01,2009-03-30,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.0099,1.07,2009-03-31,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,0.94,1.08,2009-04-01,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.2396,1.35,2009-04-02,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.0901,1.3,2009-04-03,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.19,1.19,2009-04-06,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.08,1.05,2009-04-07,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.1,1.1,2009-04-08,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.3,1.25,2009-04-09,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.1,1.08,2009-04-13,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.16,1.1,2009-04-14,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.35,1.2,2009-04-15,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.25,1.35,2009-04-16,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.3001,1.3,2009-04-17,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.2001,1.25,2009-04-20,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.16,1.25,2009-04-21,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.25,1.161,2009-04-22,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.34,1.34,2009-04-23,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.3,1.2585,2009-04-24,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.24,1.24,2009-04-27,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.51,1.54,2009-04-28,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.7,1.6,2009-04-29,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.8,1.896,2009-04-30,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.82,1.5,2009-05-01,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.7499,1.69,2009-05-04,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.68,1.6,2009-05-05,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.5899,1.65,2009-05-06,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.5501,1.62,2009-05-07,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.6001,1.5,2009-05-08,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.43,1.6,2009-05-11,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.65,1.41,2009-05-12,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.6,1.56,2009-05-13,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.6248,1.6,2009-05-14,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.75,1.61,2009-05-15,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.7,1.6,2009-05-18,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.65,1.7999,2009-05-19,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.72,1.78,2009-05-20,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.62,1.61,2009-05-21,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.5501,1.84,2009-05-22,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.6,1.6,2009-05-26,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.78,1.79,2009-05-27,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.6,1.87,2009-05-28,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.7999,1.8,2009-05-29,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.01,1.83,2009-06-01,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.04,2.04,2009-06-02,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.9,1.83,2009-06-03,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.97,1.9,2009-06-04,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.95,1.95,2009-06-05,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.89,1.76,2009-06-08,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.85,1.86,2009-06-09,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.932,1.854,2009-06-10,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.85,1.85,2009-06-11,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.86,1.86,2009-06-12,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.86,1.85,2009-06-15,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.93,1.93,2009-06-16,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.95,1.9352,2009-06-17,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.05,1.95,2009-06-18,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.0699,2.1,2009-06-19,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.85,2.03,2009-06-22,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.81,1.65,2009-06-23,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.778,1.86,2009-06-24,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.81,1.8,2009-06-25,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.8828,1.81,2009-06-26,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.88,1.81,2009-06-29,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.794,1.8501,2009-06-30,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.84,1.77,2009-07-01,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.77,1.8,2009-07-02,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.668,1.75,2009-07-06,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.67,1.72,2009-07-07,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.59,1.65,2009-07-08,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.67,1.7,2009-07-09,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.6499,1.65,2009-07-10,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.75,1.55,2009-07-13,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.62,1.66,2009-07-14,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.6599,1.61,2009-07-15,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.63,1.55,2009-07-16,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.63,1.63,2009-07-17,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.69,1.51,2009-07-20,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.594,1.66,2009-07-21,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.63,1.6,2009-07-22,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.6008,1.65,2009-07-23,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.66,1.6,2009-07-24,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.87,1.71,2009-07-27,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.34,1.81,2009-07-28,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.3,2.35,2009-07-29,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.1,2.03,2009-07-30,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.1816,2.15,2009-07-31,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.4,2.25,2009-08-03,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.35,2.45,2009-08-04,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.4499,2.35,2009-08-05,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.592,2.44,2009-08-06,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.75,2.53,2009-08-07,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.71,2.74,2009-08-10,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.59,2.5,2009-08-11,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.55,2.55,2009-08-12,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.4465,2.6,2009-08-13,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.32,2.42,2009-08-14,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.25,2.22,2009-08-17,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.2,2.16,2009-08-18,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.28,2.15,2009-08-19,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.3,2.29,2009-08-20,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.2499,2.37,2009-08-21,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.359,2.3,2009-08-24,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.34,2.34,2009-08-25,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.32,2.26,2009-08-26,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.6,2.3,2009-08-27,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.41,2.53,2009-08-28,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.75,2.42,2009-08-31,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.8997,2.8,2009-09-01,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.89,2.8,2009-09-02,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.9,2.85,2009-09-03,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.96,2.9,2009-09-04,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.15,2.97,2009-09-08,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.32,3.19,2009-09-09,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.42,3.35,2009-09-10,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.59,3.58,2009-09-11,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.05,3.63,2009-09-14,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.05,4.24,2009-09-15,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.436,4.1,2009-09-16,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.8501,4.48,2009-09-17,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,5.19,4.76,2009-09-18,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,5.81,5.24,2009-09-21,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,5.4,5.99,2009-09-22,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.61,5.4,2009-09-23,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.66,4.57,2009-09-24,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.3,4.7,2009-09-25,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.91,4.5,2009-09-28,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.83,4.93,2009-09-29,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.25,3.85,2009-09-30,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.15,3.39,2009-10-01,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.97,3.1,2009-10-02,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.18,3.02,2009-10-05,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.07,3.08,2009-10-06,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.05,3.0,2009-10-07,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.18,3.1,2009-10-08,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.21,3.12,2009-10-09,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.09,3.22,2009-10-12,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.06,3.05,2009-10-13,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.35,3.16,2009-10-14,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.351,3.33,2009-10-15,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.38,3.31,2009-10-16,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.44,3.4,2009-10-19,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.82,3.5,2009-10-20,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.81,3.82,2009-10-21,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.75,3.79,2009-10-22,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.6,3.72,2009-10-23,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.27,3.56,2009-10-26,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.18,3.27,2009-10-27,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.3,3.17,2009-10-28,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.25,3.1,2009-10-29,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.1,3.19,2009-10-30,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.05,3.1,2009-11-02,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.03,3.0,2009-11-03,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.27,3.2,2009-11-04,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.15,3.28,2009-11-05,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.1,3.16,2009-11-06,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.12,3.17,2009-11-09,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.14,3.17,2009-11-10,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.1899,3.1895,2009-11-11,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.15,3.15,2009-11-12,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.18,3.15,2009-11-13,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.27,3.19,2009-11-16,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.28,3.28,2009-11-17,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.56,3.4,2009-11-18,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.01,3.56,2009-11-19,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.09,3.99,2009-11-20,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.17,4.24,2009-11-23,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.144,4.17,2009-11-24,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.018,4.08,2009-11-25,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.98,4.05,2009-11-27,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.02,3.94,2009-11-30,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.97,4.06,2009-12-01,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.68,4.07,2009-12-02,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.64,3.604,2009-12-03,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.56,3.66,2009-12-04,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.56,3.51,2009-12-07,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.49,3.52,2009-12-08,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.25,3.5,2009-12-09,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.6,3.26,2009-12-10,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.55,3.6,2009-12-11,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.0,3.63,2009-12-14,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.0,4.1,2009-12-15,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.09,4.08,2009-12-16,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.0795,4.0,2009-12-17,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.4,4.18,2009-12-18,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.55,3.42,2009-12-21,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.52,3.55,2009-12-22,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,5.0,5.4,2009-12-23,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.23,4.85,2009-12-24,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.99,4.24,2009-12-28,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.97,4.14,2009-12-29,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.76,4.12,2009-12-30,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.59,3.8,2009-12-31,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.69,3.66,2010-01-04,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.62,3.64,2010-01-05,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.66,3.61,2010-01-06,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.87,3.7,2010-01-07,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.95,3.75,2010-01-08,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.94,3.93,2010-01-11,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.05,3.94,2010-01-12,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.0199,4.04,2010-01-13,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.0,4.1,2010-01-14,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.84,4.0,2010-01-15,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.08,3.96,2010-01-19,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.01,4.04,2010-01-20,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.9599,3.99,2010-01-21,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.0,3.9001,2010-01-22,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.87,3.96,2010-01-25,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.68,3.84,2010-01-26,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.5,3.61,2010-01-27,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.4,3.59,2010-01-28,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.52,3.37,2010-01-29,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.57,3.52,2010-02-01,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.55,3.57,2010-02-02,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.62,3.52,2010-02-03,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.5299,3.68,2010-02-04,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.5,3.49,2010-02-05,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.5,3.58,2010-02-08,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.42,3.48,2010-02-09,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.5,3.64,2010-02-10,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.44,3.42,2010-02-11,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.4,3.4,2010-02-12,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.4201,3.44,2010-02-16,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.32,3.4,2010-02-17,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.29,3.25,2010-02-18,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.5,3.24,2010-02-19,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.39,3.5,2010-02-22,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.29,3.33,2010-02-23,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.28,3.34,2010-02-24,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.3,3.28,2010-02-25,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.2281,3.25,2010-02-26,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.184,3.24,2010-03-01,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.28,3.21,2010-03-02,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.5,3.54,2010-03-03,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.58,3.48,2010-03-04,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.67,3.55,2010-03-05,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.69,3.67,2010-03-08,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.81,3.61,2010-03-09,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.95,3.76,2010-03-10,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.9,3.949,2010-03-11,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.0,3.86,2010-03-12,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.99,4.05,2010-03-15,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.95,4.0,2010-03-16,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.03,3.95,2010-03-17,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.01,4.0,2010-03-18,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.03,4.06,2010-03-19,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.9,4.01,2010-03-22,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.04,3.86,2010-03-23,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.01,4.05,2010-03-24,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.01,4.0,2010-03-25,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.97,4.06,2010-03-26,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.05,3.96,2010-03-29,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.04,4.01,2010-03-30,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.94,4.05,2010-03-31,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.9901,3.9,2010-04-01,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.01,3.91,2010-04-05,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.25,4.05,2010-04-06,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.4536,4.32,2010-04-07,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.7,4.59,2010-04-08,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.7,4.79,2010-04-09,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.83,4.83,2010-04-12,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.9799,4.7976,2010-04-13,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,5.09,4.98,2010-04-14,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,5.13,4.95,2010-04-15,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.98,5.09,2010-04-16,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.85,4.9,2010-04-19,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.88,4.86,2010-04-20,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.93,4.99,2010-04-21,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.89,4.99,2010-04-22,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.82,4.86,2010-04-23,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.76,4.79,2010-04-26,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.7,4.76,2010-04-27,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.8501,4.61,2010-04-28,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.86,4.87,2010-04-29,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.87,4.92,2010-04-30,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.99,4.96,2010-05-03,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.81,4.99,2010-05-04,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.78,4.75,2010-05-05,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.47,4.73,2010-05-06,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.486,4.48,2010-05-07,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.4,4.84,2010-05-10,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.5699,4.3,2010-05-11,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.61,4.67,2010-05-12,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.6,4.57,2010-05-13,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.42,4.65,2010-05-14,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.11,4.44,2010-05-17,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.08,4.24,2010-05-18,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.79,4.0101,2010-05-19,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.5,3.7,2010-05-20,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.87,3.5,2010-05-21,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.73,3.84,2010-05-24,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.68,3.79,2010-05-25,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.56,3.67,2010-05-26,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.6,3.6,2010-05-27,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.69,3.59,2010-05-28,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.65,3.7,2010-06-01,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.96,3.62,2010-06-02,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.89,4.0,2010-06-03,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.85,3.89,2010-06-04,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.74,3.89,2010-06-07,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.54,3.72,2010-06-08,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.65,3.65,2010-06-09,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.65,3.54,2010-06-10,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.65,3.54,2010-06-11,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.68,3.69,2010-06-14,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.68,3.76,2010-06-15,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.66,3.62,2010-06-16,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.68,3.63,2010-06-17,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.6,3.6,2010-06-18,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.59,3.67,2010-06-21,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.6,3.6,2010-06-22,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.6,3.6,2010-06-23,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.58,3.55,2010-06-24,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.4505,3.52,2010-06-25,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.37,3.46,2010-06-28,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.3,3.39,2010-06-29,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.61,3.3,2010-06-30,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.3,3.67,2010-07-01,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.27,3.33,2010-07-02,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.22,3.25,2010-07-06,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.24,3.3,2010-07-07,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.35,3.22,2010-07-08,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.5,3.56,2010-07-09,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.48,3.54,2010-07-12,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.35,3.32,2010-07-13,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.53,3.3,2010-07-14,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.27,3.27,2010-07-15,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.55,3.44,2010-07-16,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.55,3.55,2010-07-19,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.55,3.44,2010-07-20,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.51,3.6,2010-07-21,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.45,3.51,2010-07-22,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.48,3.42,2010-07-23,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.548,3.48,2010-07-26,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.41,3.49,2010-07-27,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.5,3.64,2010-07-28,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.3999,3.49,2010-07-29,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.6,3.59,2010-07-30,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.3,3.6,2010-08-02,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.21,3.34,2010-08-03,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.46,3.25,2010-08-04,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.45,3.55,2010-08-05,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.6,3.4,2010-08-06,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.41,3.54,2010-08-09,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.36,3.41,2010-08-10,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.35,3.35,2010-08-11,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.25,3.32,2010-08-12,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.48,3.23,2010-08-13,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.29,3.3999,2010-08-16,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.32,3.27,2010-08-17,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.42,3.45,2010-08-18,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.28,3.4,2010-08-19,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.34,3.28,2010-08-20,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.26,3.37,2010-08-23,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.35,3.25,2010-08-24,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.34,3.3,2010-08-25,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.31,3.29,2010-08-26,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.31,3.31,2010-08-27,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.26,3.26,2010-08-30,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.43,3.57,2010-08-31,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.46,3.58,2010-09-01,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.45,3.524,2010-09-02,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.51,3.59,2010-09-03,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.53,3.59,2010-09-07,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.53,3.59,2010-09-08,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.51,3.59,2010-09-09,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.43,3.55,2010-09-10,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.47,3.47,2010-09-13,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.5,3.49,2010-09-14,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.72,3.51,2010-09-15,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.9,3.65,2010-09-16,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.25,3.98,2010-09-17,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.16,4.23,2010-09-20,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.2,4.19,2010-09-21,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.28,4.28,2010-09-22,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.35,4.37,2010-09-23,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.415,4.35,2010-09-24,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.43,4.44,2010-09-27,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.48,4.38,2010-09-28,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.45,4.5,2010-09-29,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.38,4.46,2010-09-30,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.46,4.44,2010-10-01,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.54,4.5,2010-10-04,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.6,4.6,2010-10-05,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.6,4.62,2010-10-06,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.6,4.65,2010-10-07,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.65,4.64,2010-10-08,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.72,4.65,2010-10-11,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.85,4.76,2010-10-12,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.94,4.96,2010-10-13,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,5.21,4.98,2010-10-14,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,5.55,5.21,2010-10-15,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,5.97,5.88,2010-10-18,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,5.61,6.0,2010-10-19,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,5.89,5.6,2010-10-20,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,5.89,5.99,2010-10-21,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,5.6,5.96,2010-10-22,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,5.81,5.79,2010-10-25,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,5.76,5.94,2010-10-26,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,5.75,5.76,2010-10-27,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,5.89,5.8,2010-10-28,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,5.81,5.97,2010-10-29,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,5.72,5.89,2010-11-01,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,5.78,5.8,2010-11-02,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,5.8,5.78,2010-11-03,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,5.85,5.75,2010-11-04,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,5.979,5.9,2010-11-05,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,5.88,5.98,2010-11-08,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,5.76,5.8,2010-11-09,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,5.78,5.81,2010-11-10,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,5.53,5.79,2010-11-11,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,5.38,5.56,2010-11-12,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,5.39,5.4,2010-11-15,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,5.38,5.34,2010-11-16,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,5.25,5.42,2010-11-17,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,5.18,5.25,2010-11-18,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,5.4399,5.11,2010-11-19,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,5.18,5.32,2010-11-22,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,5.58,5.18,2010-11-23,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,5.48,5.75,2010-11-24,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,5.474,5.45,2010-11-26,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,5.21,5.36,2010-11-29,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,5.15,5.23,2010-11-30,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,5.39,5.43,2010-12-01,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,5.32,5.45,2010-12-02,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,5.3,5.3,2010-12-03,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,5.87,5.4,2010-12-06,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,5.86,5.93,2010-12-07,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,5.53,5.88,2010-12-08,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,5.24,5.37,2010-12-09,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,5.62,5.28,2010-12-10,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,5.59,5.6,2010-12-13,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,5.53,5.64,2010-12-14,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,5.57,5.49,2010-12-15,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,5.78,5.57,2010-12-16,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,5.7,5.715,2010-12-17,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,5.88,5.79,2010-12-20,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,6.73,5.94,2010-12-21,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,6.47,6.8,2010-12-22,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,6.36,6.5,2010-12-23,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,5.19,4.85,2010-12-27,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,5.18,5.15,2010-12-28,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,5.082,5.14,2010-12-29,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,5.05,5.05,2010-12-30,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,5.11,5.05,2010-12-31,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,5.05,5.08,2011-01-03,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,5.02,5.03,2011-01-04,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,5.06,5.01,2011-01-05,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,5.05,5.08,2011-01-06,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.99,5.06,2011-01-07,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,5.09,5.07,2011-01-10,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,5.05,5.1,2011-01-11,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,5.04,5.08,2011-01-12,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,5.02,5.08,2011-01-13,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,5.0,5.02,2011-01-14,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.91,4.95,2011-01-18,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.85,4.76,2011-01-19,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.69,4.91,2011-01-20,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.53,4.63,2011-01-21,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.5,4.5,2011-01-24,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.5,4.5,2011-01-25,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.55,4.6,2011-01-26,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.76,4.589,2011-01-27,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.88,4.83,2011-01-28,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,5.0,4.9,2011-01-31,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.81,4.99,2011-02-01,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.73,4.65,2011-02-02,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.83,4.71,2011-02-03,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.42,4.76,2011-02-04,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.1,4.45,2011-02-07,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.25,4.2,2011-02-08,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.1,4.1401,2011-02-09,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.1,4.01,2011-02-10,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.01,4.11,2011-02-11,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.07,4.0,2011-02-14,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.08,4.03,2011-02-15,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.85,4.0799,2011-02-16,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.86,3.87,2011-02-17,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.84,3.83,2011-02-18,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.8,3.8,2011-02-22,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.81,3.8,2011-02-23,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.81,3.79,2011-02-24,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.84,3.81,2011-02-25,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.95,3.89,2011-02-28,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.94,3.96,2011-03-01,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.87,3.95,2011-03-02,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.85,3.88,2011-03-03,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.87,3.9,2011-03-04,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.85,3.86,2011-03-07,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.98,3.87,2011-03-08,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.9,4.0,2011-03-09,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.898,3.9,2011-03-10,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.0,3.85,2011-03-11,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.058,3.99,2011-03-14,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.07,3.97,2011-03-15,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.91,4.07,2011-03-16,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.9,3.96,2011-03-17,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.98,3.89,2011-03-18,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.91,3.97,2011-03-21,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.91,3.94,2011-03-22,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.95,3.901,2011-03-23,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.06,3.95,2011-03-24,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.92,4.08,2011-03-25,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.91,3.92,2011-03-28,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.86,3.9,2011-03-29,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.9199,3.91,2011-03-30,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.92,3.89,2011-03-31,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.97,3.92,2011-04-01,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.9999,4.0,2011-04-04,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.95,3.97,2011-04-05,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.94,3.95,2011-04-06,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.96,3.95,2011-04-07,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.95,3.95,2011-04-08,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.16,3.95,2011-04-11,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.35,4.2,2011-04-12,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.35,4.38,2011-04-13,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.5,4.3101,2011-04-14,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.38,4.53,2011-04-15,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.36,4.36,2011-04-18,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.38,4.36,2011-04-19,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.38,4.37,2011-04-20,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.38,4.35,2011-04-21,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.35,4.36,2011-04-25,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.36,4.33,2011-04-26,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.34,4.39,2011-04-27,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.36,4.34,2011-04-28,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.36,4.34,2011-04-29,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.4,4.35,2011-05-02,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.37,4.45,2011-05-03,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.25,4.35,2011-05-04,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.12,4.22,2011-05-05,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.2,4.18,2011-05-06,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.02,4.23,2011-05-09,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.82,4.02,2011-05-10,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.93,3.85,2011-05-11,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.88,3.92,2011-05-12,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.85,3.94,2011-05-13,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.78,3.87,2011-05-16,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.52,3.8,2011-05-17,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.54,3.52,2011-05-18,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.9,3.57,2011-05-19,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.05,3.94,2011-05-20,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.93,4.1,2011-05-23,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.05,3.89,2011-05-24,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.15,4.1,2011-05-25,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.2,4.17,2011-05-26,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.32,4.23,2011-05-27,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.47,4.39,2011-05-31,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.5,4.53,2011-06-01,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.3,4.44,2011-06-02,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.35,4.31,2011-06-03,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.33,4.33,2011-06-06,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.3,4.35,2011-06-07,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.25,4.3,2011-06-08,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.24,4.25,2011-06-09,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.06,4.24,2011-06-10,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.9,4.18,2011-06-13,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.0,4.15,2011-06-14,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.02,3.97,2011-06-15,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.995,4.05,2011-06-16,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.03,4.05,2011-06-17,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.0,4.05,2011-06-20,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.1,3.99,2011-06-21,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.21,4.1,2011-06-22,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.25,4.15,2011-06-23,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.31,4.23,2011-06-24,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.22,4.29,2011-06-27,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.09,4.15,2011-06-28,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.23,4.12,2011-06-29,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.28,4.27,2011-06-30,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.3,4.28,2011-07-01,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.47,4.27,2011-07-05,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.53,4.48,2011-07-06,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.78,4.57,2011-07-07,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.87,4.89,2011-07-08,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.82,4.84,2011-07-11,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.95,4.82,2011-07-12,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,5.02,4.96,2011-07-13,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,5.16,5.05,2011-07-14,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,5.05,5.16,2011-07-15,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.9,5.02,2011-07-18,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,5.03,4.95,2011-07-19,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,5.02,5.08,2011-07-20,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,5.05,5.04,2011-07-21,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,5.089,5.07,2011-07-22,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.91,4.97,2011-07-25,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.88,4.93,2011-07-26,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.69,4.79,2011-07-27,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.7,4.73,2011-07-28,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.7,4.7,2011-07-29,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.84,4.76,2011-08-01,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.71,4.83,2011-08-02,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.76,4.72,2011-08-03,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.384,4.73,2011-08-04,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.27,4.38,2011-08-05,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.13,4.0,2011-08-08,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.18,4.14,2011-08-09,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.15,4.12,2011-08-10,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.21,4.15,2011-08-11,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.21,4.25,2011-08-12,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.26,4.24,2011-08-15,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.43,4.26,2011-08-16,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.41,4.51,2011-08-17,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.405,4.34,2011-08-18,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.36,4.4,2011-08-19,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.34,4.39,2011-08-22,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.33,4.31,2011-08-23,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.41,4.2936,2011-08-24,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.34,4.42,2011-08-25,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.43,4.29,2011-08-26,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.62,4.48,2011-08-29,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.54,4.61,2011-08-30,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.45,4.57,2011-08-31,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.43,4.35,2011-09-01,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.44,4.33,2011-09-02,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.41,4.4,2011-09-06,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.51,4.45,2011-09-07,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.5346,4.51,2011-09-08,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.43,4.51,2011-09-09,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.31,4.38,2011-09-12,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.31,4.31,2011-09-13,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.36,4.27,2011-09-14,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.4,4.36,2011-09-15,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.44,4.4,2011-09-16,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.43,4.36,2011-09-19,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.5,4.44,2011-09-20,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.44,4.55,2011-09-21,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.27,4.36,2011-09-22,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.13,4.29,2011-09-23,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.19,4.15,2011-09-26,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.35,4.23,2011-09-27,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.4,4.43,2011-09-28,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.36,4.47,2011-09-29,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.27,4.37,2011-09-30,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.95,4.21,2011-10-03,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.79,3.95,2011-10-04,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.73,3.8,2011-10-05,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.9699,3.78,2011-10-06,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.93,3.96,2011-10-07,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.1,4.02,2011-10-10,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.24,4.14,2011-10-11,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.12,4.27,2011-10-12,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.11,4.09,2011-10-13,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.12,4.13,2011-10-14,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.09,4.1,2011-10-17,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.93,4.05,2011-10-18,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.98,3.94,2011-10-19,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.1171,3.99,2011-10-20,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.15,4.25,2011-10-21,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.1499,4.16,2011-10-24,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.01,4.15,2011-10-25,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.12,4.09,2011-10-26,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.11,4.2,2011-10-27,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.61,4.09,2011-10-28,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.59,4.66,2011-10-31,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.66,4.48,2011-11-01,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.63,4.76,2011-11-02,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.59,4.72,2011-11-03,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.14,4.54,2011-11-04,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.4,4.1,2011-11-07,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.22,4.35,2011-11-08,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.16,4.13,2011-11-09,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.93,4.19,2011-11-10,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.025,3.9,2011-11-11,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.59,1.82,2011-11-14,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.4,1.58,2011-11-15,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.34,1.4,2011-11-16,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.34,1.46,2011-11-17,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.26,1.31,2011-11-18,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.08,1.25,2011-11-21,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.18,1.15,2011-11-22,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.18,1.2,2011-11-23,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.2,1.2,2011-11-25,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.21,1.21,2011-11-28,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.34,1.24,2011-11-29,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.44,1.39,2011-11-30,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.41,1.41,2011-12-01,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.4,1.49,2011-12-02,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.32,1.4,2011-12-05,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.32,1.3,2011-12-06,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.32,1.31,2011-12-07,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.28,1.31,2011-12-08,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.258,1.25,2011-12-09,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.35,1.25,2011-12-12,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.2,1.36,2011-12-13,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.17,1.16,2011-12-14,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.175,1.17,2011-12-15,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.15,1.15,2011-12-16,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.1,1.13,2011-12-19,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.18,1.1,2011-12-20,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.19,1.15,2011-12-21,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.23,1.2,2011-12-22,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.23,1.27,2011-12-23,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.21,1.23,2011-12-27,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.14,1.2,2011-12-28,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.1,1.12,2011-12-29,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.11,1.1,2011-12-30,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.15,1.13,2012-01-03,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.19,1.18,2012-01-04,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.17,1.2,2012-01-05,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.21,1.18,2012-01-06,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.24,1.2,2012-01-09,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.23,1.24,2012-01-10,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.18,1.25,2012-01-11,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.2,1.17,2012-01-12,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.2,1.2,2012-01-13,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.17,1.21,2012-01-17,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.19,1.18,2012-01-18,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.19,1.18,2012-01-19,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.18,1.19,2012-01-20,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.2,1.16,2012-01-23,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.2,1.2,2012-01-24,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.209,1.22,2012-01-25,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.16,1.19,2012-01-26,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.21,1.15,2012-01-27,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.18,1.2,2012-01-30,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.2,1.165,2012-01-31,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.17,1.2,2012-02-01,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.24,1.2,2012-02-02,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.27,1.19,2012-02-03,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.3,1.26,2012-02-06,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.28,1.32,2012-02-07,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.24,1.28,2012-02-08,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.24,1.16,2012-02-09,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.231,1.23,2012-02-10,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.2,1.22,2012-02-13,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.16,1.18,2012-02-14,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.16,1.19,2012-02-15,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.15,1.16,2012-02-16,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.16,1.15,2012-02-17,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.15,1.18,2012-02-21,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.165,1.13,2012-02-22,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.17,1.18,2012-02-23,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.74,1.18,2012-02-24,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.15,2.25,2012-02-27,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.42,2.8,2012-02-28,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.14,2.43,2012-02-29,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.04,2.17,2012-03-01,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.95,2.01,2012-03-02,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.1,1.95,2012-03-05,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.92,2.06,2012-03-06,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.81,1.9,2012-03-07,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.79,1.84,2012-03-08,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.71,1.79,2012-03-09,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.75,1.76,2012-03-12,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.7799,1.77,2012-03-13,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.8,1.78,2012-03-14,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.69,1.78,2012-03-15,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.74,1.7,2012-03-16,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.65,1.76,2012-03-19,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.57,1.66,2012-03-20,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.56,1.6,2012-03-21,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.58,1.56,2012-03-22,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.61,1.58,2012-03-23,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.83,1.63,2012-03-26,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.497,2.05,2012-03-27,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.05,2.35,2012-03-28,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.97,2.05,2012-03-29,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.86,1.97,2012-03-30,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.845,1.92,2012-04-02,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.76,1.88,2012-04-03,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.7,1.78,2012-04-04,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.6,1.66,2012-04-05,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.57,1.6,2012-04-09,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.62,1.57,2012-04-10,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.68,1.62,2012-04-11,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.68,1.69,2012-04-12,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.83,1.68,2012-04-13,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.95,1.8999,2012-04-16,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.13,2.0,2012-04-17,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.04,2.14,2012-04-18,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.11,2.03,2012-04-19,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.17,2.14,2012-04-20,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.3,2.15,2012-04-23,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.46,2.42,2012-04-24,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.42,2.49,2012-04-25,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.44,2.48,2012-04-26,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.4,2.49,2012-04-27,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.3,2.39,2012-04-30,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.25,2.28,2012-05-01,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.25,2.1701,2012-05-02,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.22,2.2,2012-05-03,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.12,2.21,2012-05-04,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.22,2.15,2012-05-07,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.29,2.3,2012-05-08,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.17,2.28,2012-05-09,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.16,2.16,2012-05-10,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.19,2.15,2012-05-11,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.13,2.19,2012-05-14,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.14,2.12,2012-05-15,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.17,2.18,2012-05-16,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.125,2.18,2012-05-17,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.0,2.15,2012-05-18,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.03,2.01,2012-05-21,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.09,2.05,2012-05-22,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.06,2.07,2012-05-23,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.05,2.07,2012-05-24,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.11,2.06,2012-05-25,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.05,2.11,2012-05-29,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.04,2.02,2012-05-30,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.98,2.07,2012-05-31,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.89,1.99,2012-06-01,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.79,1.83,2012-06-04,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.88,1.82,2012-06-05,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.9309,1.9,2012-06-06,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.0695,1.94,2012-06-07,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.99,2.05,2012-06-08,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.9301,1.99,2012-06-11,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.89,1.93,2012-06-12,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.87,1.8101,2012-06-13,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.8601,1.89,2012-06-14,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.81,1.84,2012-06-15,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.88,1.8,2012-06-18,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.92,1.8501,2012-06-19,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.95,1.91,2012-06-20,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.78,1.95,2012-06-21,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.89,1.81,2012-06-22,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.88,1.87,2012-06-25,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.2499,1.8799,2012-06-26,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.35,2.4,2012-06-27,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.33,2.49,2012-06-28,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.31,2.33,2012-06-29,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.24,2.31,2012-07-02,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.19,2.2,2012-07-03,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.24,2.21,2012-07-05,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.22,2.238,2012-07-06,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.25,2.2,2012-07-09,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.2,2.31,2012-07-10,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.19,2.23,2012-07-11,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.16,2.16,2012-07-12,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.12,2.16,2012-07-13,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.14,2.1,2012-07-16,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.05,2.12,2012-07-17,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.14,2.05,2012-07-18,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.74,2.44,2012-07-19,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.41,2.62,2012-07-20,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.312,2.36,2012-07-23,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.48,2.35,2012-07-24,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.3,2.46,2012-07-25,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.39,2.61,2012-07-26,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.76,2.45,2012-07-27,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.94,2.96,2012-07-30,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.76,2.95,2012-07-31,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.4,2.77,2012-08-01,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.08,2.27,2012-08-02,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.07,2.12,2012-08-03,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.09,2.08,2012-08-06,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.09,2.1,2012-08-07,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.7,2.03,2012-08-08,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.81,1.73,2012-08-09,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.8,1.82,2012-08-10,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.76,1.82,2012-08-13,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.76,1.76,2012-08-14,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.7,1.73,2012-08-15,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.67,1.7,2012-08-16,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.6988,1.69,2012-08-17,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.67,1.7,2012-08-20,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.68,1.65,2012-08-21,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.69,1.66,2012-08-22,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.72,1.68,2012-08-23,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.8,1.72,2012-08-24,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.8,1.8,2012-08-27,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.79,1.7899,2012-08-28,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.78,1.8,2012-08-29,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.76,1.77,2012-08-30,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.7408,1.8,2012-08-31,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.706,1.77,2012-09-04,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.7,1.68,2012-09-05,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.75,1.7,2012-09-06,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.76,1.72,2012-09-07,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.79,1.74,2012-09-10,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.77,1.79,2012-09-11,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.77,1.75,2012-09-12,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.76,1.78,2012-09-13,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.76,1.79,2012-09-14,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.68,1.72,2012-09-17,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.69,1.68,2012-09-18,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.69,1.68,2012-09-19,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.68,1.6514,2012-09-20,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.62,1.68,2012-09-21,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.69,1.6,2012-09-24,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.67,1.69,2012-09-25,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.64,1.67,2012-09-26,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.64,1.64,2012-09-27,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.63,1.636,2012-09-28,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.62,1.64,2012-10-01,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.64,1.6101,2012-10-02,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.62,1.64,2012-10-03,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.65,1.61,2012-10-04,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.63,1.65,2012-10-05,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.59,1.65,2012-10-08,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.59,1.57,2012-10-09,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.549,1.57,2012-10-10,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.55,1.57,2012-10-11,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.56,1.57,2012-10-12,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.54,1.563,2012-10-15,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.58,1.57,2012-10-16,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.63,1.57,2012-10-17,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.58,1.62,2012-10-18,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.58,1.57,2012-10-19,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.57,1.57,2012-10-22,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.54,1.56,2012-10-23,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.53,1.53,2012-10-24,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.54,1.54,2012-10-25,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.54,1.54,2012-10-26,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.56,1.56,2012-10-31,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.55,1.58,2012-11-01,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.55,1.56,2012-11-02,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.55,1.54,2012-11-05,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.56,1.56,2012-11-06,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.53,1.53,2012-11-07,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.42,1.43,2012-11-08,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.43,1.45,2012-11-09,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.45,1.42,2012-11-12,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.38,1.42,2012-11-13,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.37,1.41,2012-11-14,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.299,1.35,2012-11-15,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.25,1.32,2012-11-16,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.308,1.26,2012-11-19,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.33,1.34,2012-11-20,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.39,1.35,2012-11-21,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.41,1.43,2012-11-23,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.36,1.385,2012-11-26,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.33,1.35,2012-11-27,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.35,1.35,2012-11-28,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.37,1.36,2012-11-29,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.3,1.36,2012-11-30,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.29,1.29,2012-12-03,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.3,1.33,2012-12-04,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.3,1.33,2012-12-05,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.3,1.3,2012-12-06,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.28,1.32,2012-12-07,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.29,1.3,2012-12-10,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.3,1.27,2012-12-11,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.3,1.28,2012-12-12,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.26,1.27,2012-12-13,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.33,1.28,2012-12-14,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.35,1.4,2012-12-17,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.45,1.44,2012-12-18,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.3199,1.46,2012-12-19,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.27,1.32,2012-12-20,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.25,1.27,2012-12-21,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.23,1.23,2012-12-24,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.28,1.22,2012-12-26,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.3,1.3,2012-12-27,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.25,1.3,2012-12-28,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.21,1.25,2012-12-31,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.259,1.23,2013-01-02,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.2347,1.24,2013-01-03,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.29,1.22,2013-01-04,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.35,1.26,2013-01-07,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.3495,1.37,2013-01-08,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.4,1.3101,2013-01-09,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.48,1.44,2013-01-10,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.44,1.442,2013-01-11,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.44,1.45,2013-01-14,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.4,1.4,2013-01-15,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.4,1.373,2013-01-16,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.45,1.47,2013-01-17,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.46,1.47,2013-01-18,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.42,1.44,2013-01-22,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.42,1.38,2013-01-23,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.4,1.39,2013-01-24,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.36,1.3302,2013-01-25,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.4099,1.38,2013-01-28,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.4,1.41,2013-01-29,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.39,1.41,2013-01-30,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.37,1.3702,2013-01-31,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.61,1.38,2013-02-01,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.55,1.61,2013-02-04,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.61,1.58,2013-02-05,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.56,1.61,2013-02-06,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.54,1.53,2013-02-07,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.53,1.54,2013-02-08,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.58,1.57,2013-02-11,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.61,1.553,2013-02-12,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.61,1.611,2013-02-13,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.6,1.58,2013-02-14,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.67,1.6001,2013-02-15,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.76,1.65,2013-02-19,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.761,1.78,2013-02-20,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.8,1.74,2013-02-21,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.13,1.79,2013-02-22,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.01,2.15,2013-02-25,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.0001,1.97,2013-02-26,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.01,1.99,2013-02-27,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.15,2.02,2013-02-28,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.121,2.09,2013-03-01,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.15,2.1,2013-03-04,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.16,2.14,2013-03-05,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.24,2.1701,2013-03-06,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.23,2.24,2013-03-07,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.18,2.2326,2013-03-08,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.13,2.17,2013-03-11,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.12,2.14,2013-03-12,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.13,2.09,2013-03-13,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.0901,2.08,2013-03-14,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.1,2.045,2013-03-15,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.03,2.09,2013-03-18,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.99,2.0,2013-03-19,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.05,2.0,2013-03-20,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.08,2.09,2013-03-21,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.12,2.2,2013-03-22,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.19,2.12,2013-03-25,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.28,2.23,2013-03-26,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.35,2.3,2013-03-27,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.2901,2.31,2013-03-28,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.38,2.34,2013-04-01,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.29,2.38,2013-04-02,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.26,2.32,2013-04-03,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.27,2.5,2013-04-04,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.26,2.22,2013-04-05,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.24,2.24,2013-04-08,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.23,2.22,2013-04-09,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.33,2.3,2013-04-10,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.38,2.34,2013-04-11,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.35,2.39,2013-04-12,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.26,2.36,2013-04-15,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.28,2.27,2013-04-16,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.25,2.3,2013-04-17,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.27,2.23,2013-04-18,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.25,2.25,2013-04-19,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.28,2.28,2013-04-22,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.24,2.33,2013-04-23,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.2,2.21,2013-04-24,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.18,2.24,2013-04-25,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.17,2.24,2013-04-26,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.27,2.22,2013-04-29,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.27,2.27,2013-04-30,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.35,2.29,2013-05-01,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.57,2.32,2013-05-02,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.77,2.75,2013-05-03,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.71,2.8,2013-05-06,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.74,2.78,2013-05-07,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.82,2.77,2013-05-08,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.73,2.85,2013-05-09,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.82,2.76,2013-05-10,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.89,2.86,2013-05-13,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.82,2.98,2013-05-14,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.85,2.82,2013-05-15,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.79,2.82,2013-05-16,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.83,2.86,2013-05-17,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.0,2.8,2013-05-20,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.97,3.03,2013-05-21,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.0,2.97,2013-05-22,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.08,3.01,2013-05-23,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.2,3.09,2013-05-24,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.16,3.24,2013-05-28,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.35,3.16,2013-05-29,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.44,3.33,2013-05-30,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.25,3.46,2013-05-31,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.36,3.29,2013-06-03,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.3,3.39,2013-06-04,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.3,3.32,2013-06-05,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.37,3.3,2013-06-06,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.4,3.38,2013-06-07,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.54,3.44,2013-06-10,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.58,3.53,2013-06-11,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.47,3.6,2013-06-12,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.37,3.44,2013-06-13,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.43,3.45,2013-06-14,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.72,3.5,2013-06-17,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.84,3.79,2013-06-18,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.94,3.9,2013-06-19,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.91,3.94,2013-06-20,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.77,3.96,2013-06-21,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.63,3.68,2013-06-24,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.77,3.63,2013-06-25,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.82,3.78,2013-06-26,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.84,3.89,2013-06-27,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.87,3.81,2013-06-28,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.81,3.94,2013-07-01,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.86,3.87,2013-07-02,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.81,3.82,2013-07-03,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.86,3.8,2013-07-05,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.87,3.86,2013-07-08,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.83,3.9,2013-07-09,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.81,3.86,2013-07-10,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.66,3.83,2013-07-11,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.38,3.62,2013-07-12,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.52,3.4,2013-07-15,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.59,3.58,2013-07-16,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.72,3.62,2013-07-17,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.42,3.68,2013-07-18,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.45,3.4,2013-07-19,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.44,3.38,2013-07-22,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.51,3.46,2013-07-23,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.57,3.69,2013-07-24,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.56,3.54,2013-07-25,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.52,3.56,2013-07-26,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.69,3.55,2013-07-29,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.72,3.73,2013-07-30,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.77,3.75,2013-07-31,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.76,3.77,2013-08-01,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.68,3.77,2013-08-02,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.67,3.67,2013-08-05,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.6,3.69,2013-08-06,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.52,3.59,2013-08-07,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.5,3.53,2013-08-08,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.46,3.54,2013-08-09,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.45,3.45,2013-08-12,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.4,3.46,2013-08-13,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.28,3.44,2013-08-14,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.45,3.26,2013-08-15,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.43,3.48,2013-08-16,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.33,3.42,2013-08-19,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.33,3.35,2013-08-20,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.28,3.33,2013-08-21,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.44,3.29,2013-08-22,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.43,3.42,2013-08-23,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.56,3.45,2013-08-26,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.47,3.56,2013-08-27,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.61,3.47,2013-08-28,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.65,3.61,2013-08-29,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.62,3.66,2013-08-30,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.6,3.64,2013-09-03,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.58,3.6,2013-09-04,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.67,3.56,2013-09-05,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.79,3.66,2013-09-06,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.79,3.79,2013-09-09,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.7501,3.8,2013-09-10,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.79,3.76,2013-09-11,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.04,3.8,2013-09-12,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.9,4.04,2013-09-13,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.96,3.94,2013-09-16,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.04,3.99,2013-09-17,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.05,4.07,2013-09-18,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.25,4.1,2013-09-19,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.11,4.25,2013-09-20,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.03,4.16,2013-09-23,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.05,4.03,2013-09-24,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.14,4.09,2013-09-25,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.14,3.99,2013-09-26,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.2,4.23,2013-09-27,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.11,4.14,2013-09-30,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,5.38,4.25,2013-10-01,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,5.15,5.4,2013-10-02,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.67,5.07,2013-10-03,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.78,4.69,2013-10-04,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,5.07,5.09,2013-10-07,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,5.07,5.37,2013-10-08,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.72,5.13,2013-10-09,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.78,4.83,2013-10-10,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.61,4.75,2013-10-11,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.32,4.61,2013-10-14,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.51,4.3,2013-10-15,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.57,4.51,2013-10-16,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.8,4.39,2013-10-17,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.87,2.33,2013-10-18,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.65,2.76,2013-10-21,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.65,2.62,2013-10-22,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.64,2.62,2013-10-23,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.65,2.62,2013-10-24,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.56,2.54,2013-10-25,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.52,2.52,2013-10-28,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.6,2.53,2013-10-29,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.43,2.57,2013-10-30,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.45,2.41,2013-10-31,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.54,2.45,2013-11-01,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.55,2.54,2013-11-04,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.53,2.53,2013-11-05,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.46,2.55,2013-11-06,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.38,2.5,2013-11-07,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.47,2.42,2013-11-08,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.51,2.49,2013-11-11,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.43,2.52,2013-11-12,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.495,2.44,2013-11-13,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.5,2.48,2013-11-14,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.48,2.47,2013-11-15,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.6,2.48,2013-11-18,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.66,2.61,2013-11-19,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.605,2.64,2013-11-20,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.61,2.62,2013-11-21,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.62,2.61,2013-11-22,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.68,2.63,2013-11-25,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.0,2.69,2013-11-26,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.93,3.0,2013-11-27,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.92,2.95,2013-11-29,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.95,2.93,2013-12-02,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.82,2.97,2013-12-03,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.84,2.82,2013-12-04,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.8,2.83,2013-12-05,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.74,2.84,2013-12-06,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.7,2.77,2013-12-09,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.69,2.68,2013-12-10,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.62,2.65,2013-12-11,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.67,2.61,2013-12-12,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.76,2.69,2013-12-13,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.82,2.78,2013-12-16,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.97,2.84,2013-12-17,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.97,2.93,2013-12-18,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.01,4.57,2013-12-19,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.92,3.92,2013-12-20,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.99,4.08,2013-12-23,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.01,4.02,2013-12-24,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.0,4.02,2013-12-26,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.95,4.01,2013-12-27,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.01,3.94,2013-12-30,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.97,4.01,2013-12-31,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.91,3.95,2014-01-02,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.98,3.88,2014-01-03,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.92,4.02,2014-01-06,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.9,3.97,2014-01-07,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.98,3.88,2014-01-08,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.99,3.99,2014-01-09,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.12,3.95,2014-01-10,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.13,4.22,2014-01-13,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.21,4.15,2014-01-14,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.3,4.25,2014-01-15,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.57,4.3,2014-01-16,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.91,4.6,2014-01-17,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,5.02,4.9,2014-01-21,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,5.0,5.05,2014-01-22,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.97,4.97,2014-01-23,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.63,4.91,2014-01-24,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.58,4.71,2014-01-27,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.96,4.56,2014-01-28,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.82,5.09,2014-01-29,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.63,4.91,2014-01-30,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.7,4.64,2014-01-31,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.48,4.73,2014-02-03,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.4,4.48,2014-02-04,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.38,4.4,2014-02-05,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.32,4.36,2014-02-06,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.5,4.33,2014-02-07,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.52,4.6,2014-02-10,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.5,4.501,2014-02-11,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.62,4.48,2014-02-12,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.51,4.56,2014-02-13,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.36,4.52,2014-02-14,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.38,4.4,2014-02-18,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.49,4.38,2014-02-19,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.55,4.48,2014-02-20,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.61,4.58,2014-02-21,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.48,4.6,2014-02-24,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.52,4.53,2014-02-25,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.44,4.55,2014-02-26,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.4,4.44,2014-02-27,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.38,4.39,2014-02-28,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.28,4.29,2014-03-03,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.37,4.34,2014-03-04,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.37,4.38,2014-03-05,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.36,4.37,2014-03-06,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.25,4.35,2014-03-07,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.395,4.28,2014-03-10,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.38,4.4,2014-03-11,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.42,4.38,2014-03-12,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.32,4.4,2014-03-13,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.37,4.35,2014-03-14,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.35,4.36,2014-03-17,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.42,4.4,2014-03-18,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.37,4.41,2014-03-19,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.43,4.33,2014-03-20,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.44,4.43,2014-03-21,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.31,4.41,2014-03-24,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.22,4.34,2014-03-25,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.23,4.23,2014-03-26,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.01,4.19,2014-03-27,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.89,4.04,2014-03-28,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.1,3.96,2014-03-31,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.12,4.1,2014-04-01,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.21,4.16,2014-04-02,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.06,4.17,2014-04-03,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.83,4.07,2014-04-04,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.71,3.83,2014-04-07,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.62,3.67,2014-04-08,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.82,3.65,2014-04-09,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.49,3.76,2014-04-10,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.43,3.44,2014-04-11,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.41,3.5,2014-04-14,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.51,3.45,2014-04-15,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.56,3.52,2014-04-16,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.45,3.514,2014-04-17,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.48,3.48,2014-04-21,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.68,3.54,2014-04-22,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.67,3.63,2014-04-23,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.67,3.63,2014-04-24,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.52,3.63,2014-04-25,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.62,3.52,2014-04-28,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.69,3.66,2014-04-29,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.64,3.64,2014-04-30,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.63,3.62,2014-05-01,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.65,3.66,2014-05-02,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.95,3.61,2014-05-05,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.7,3.99,2014-05-06,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.63,3.69,2014-05-07,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.45,3.65,2014-05-08,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.49,3.4,2014-05-09,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.59,3.49,2014-05-12,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.4,3.68,2014-05-13,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.67,3.71,2014-05-14,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.67,3.74,2014-05-15,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.65,3.7,2014-05-16,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.74,3.61,2014-05-19,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.69,3.68,2014-05-20,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.69,3.682,2014-05-21,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.72,3.749,2014-05-22,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.66,3.71,2014-05-23,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.68,3.71,2014-05-27,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.71,3.65,2014-05-28,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.87,3.73,2014-05-29,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.85,3.84,2014-05-30,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.79,3.89,2014-06-02,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.72,3.75,2014-06-03,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.61,3.7001,2014-06-04,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.64,3.61,2014-06-05,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.77,3.63,2014-06-06,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.82,3.75,2014-06-09,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.88,3.83,2014-06-10,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.98,3.88,2014-06-11,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.99,3.91,2014-06-12,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.04,3.99,2014-06-13,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.01,4.04,2014-06-16,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.01,4.0,2014-06-17,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.98,4.0,2014-06-18,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.04,3.98,2014-06-19,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.99,4.0,2014-06-20,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.0,4.0,2014-06-23,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.16,4.05,2014-06-24,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.13,4.15,2014-06-25,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.07,4.15,2014-06-26,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.15,4.08,2014-06-27,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.34,4.24,2014-06-30,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.33,4.34,2014-07-01,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.69,4.34,2014-07-02,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.65,4.69,2014-07-03,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.69,4.66,2014-07-07,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.52,4.65,2014-07-08,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.55,4.55,2014-07-09,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.52,4.55,2014-07-10,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.64,4.56,2014-07-11,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.62,4.69,2014-07-14,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.47,4.62,2014-07-15,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.45,4.483,2014-07-16,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.23,4.42,2014-07-17,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.41,4.29,2014-07-18,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.31,4.37,2014-07-21,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.38,4.3599,2014-07-22,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.44,4.42,2014-07-23,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.43,4.462,2014-07-24,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.38,4.38,2014-07-25,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.36,4.42,2014-07-28,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.54,4.36,2014-07-29,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.53,4.59,2014-07-30,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.46,4.48,2014-07-31,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.38,4.4,2014-08-01,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.33,4.36,2014-08-04,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.4,4.33,2014-08-05,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.39,4.36,2014-08-06,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.35,4.37,2014-08-07,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.39,4.42,2014-08-08,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.49,4.44,2014-08-11,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.38,4.52,2014-08-12,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.58,4.41,2014-08-13,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.71,4.68,2014-08-14,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.79,4.78,2014-08-15,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.79,4.79,2014-08-18,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.81,4.87,2014-08-19,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.66,4.82,2014-08-20,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.61,4.697,2014-08-21,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.73,4.61,2014-08-22,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.77,4.77,2014-08-25,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.76,4.73,2014-08-26,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.8,4.77,2014-08-27,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.8,4.75,2014-08-28,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.82,4.78,2014-08-29,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.78,4.86,2014-09-02,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.79,4.85,2014-09-03,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.79,4.88,2014-09-04,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.78,4.77,2014-09-05,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.77,4.82,2014-09-08,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.71,4.75,2014-09-09,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.7,4.72,2014-09-10,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.54,4.66,2014-09-11,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.44,4.54,2014-09-12,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.21,4.41,2014-09-15,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.04,4.0,2014-09-16,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.06,4.11,2014-09-17,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.29,4.05,2014-09-18,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.24,4.25,2014-09-19,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.18,4.26,2014-09-22,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.17,4.21,2014-09-23,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.21,4.24,2014-09-24,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.28,4.26,2014-09-25,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.29,4.4,2014-09-26,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.3,4.68,2014-09-29,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.42,4.35,2014-09-30,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.05,4.33,2014-10-01,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.26,4.05,2014-10-02,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.27,4.26,2014-10-03,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.15,4.39,2014-10-06,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.95,4.1,2014-10-07,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.98,3.92,2014-10-08,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.75,3.95,2014-10-09,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.68,3.74,2014-10-10,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.66,3.65,2014-10-13,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.65,3.66,2014-10-14,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.63,3.61,2014-10-15,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.71,3.53,2014-10-16,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.68,3.87,2014-10-17,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.72,3.71,2014-10-20,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.7,3.73,2014-10-21,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.74,3.69,2014-10-22,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.07,3.75,2014-10-23,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.23,4.1,2014-10-24,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.15,4.25,2014-10-27,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.09,4.1,2014-10-28,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.11,4.06,2014-10-29,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.09,4.09,2014-10-30,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.94,4.13,2014-10-31,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.79,3.92,2014-11-03,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.75,3.74,2014-11-04,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.66,3.8,2014-11-05,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.68,3.67,2014-11-06,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.52,3.88,2014-11-07,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.72,3.54,2014-11-10,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.61,3.7,2014-11-11,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.74,3.64,2014-11-12,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.57,3.72,2014-11-13,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.67,3.59,2014-11-14,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.59,3.69,2014-11-17,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.6,3.59,2014-11-18,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.58,3.62,2014-11-19,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.9,3.64,2014-11-20,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.9,3.9,2014-11-21,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.05,3.92,2014-11-24,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.26,4.09,2014-11-25,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.39,4.29,2014-11-26,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.31,4.39,2014-11-28,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.26,4.36,2014-12-01,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.4,4.37,2014-12-02,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.4,4.45,2014-12-03,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.32,4.42,2014-12-04,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.46,4.32,2014-12-05,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.37,4.47,2014-12-08,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.54,4.35,2014-12-09,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.52,4.56,2014-12-10,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.39,4.58,2014-12-11,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.4,4.31,2014-12-12,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.21,4.43,2014-12-15,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.09,4.16,2014-12-16,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.1,4.05,2014-12-17,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.22,4.13,2014-12-18,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.27,4.22,2014-12-19,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.22,4.27,2014-12-22,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.03,4.28,2014-12-23,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.0,4.01,2014-12-24,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.02,4.01,2014-12-26,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.12,4.05,2014-12-29,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.12,4.1,2014-12-30,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.11,4.1,2014-12-31,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.16,4.17,2015-01-02,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.1,4.21,2015-01-05,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.02,4.1,2015-01-06,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.04,4.1,2015-01-07,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.08,4.1,2015-01-08,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.07,4.13,2015-01-09,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.02,4.1,2015-01-12,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.97,4.04,2015-01-13,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.07,4.02,2015-01-14,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.99,4.07,2015-01-15,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.06,4.0,2015-01-16,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.11,4.28,2015-01-20,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.06,4.1,2015-01-21,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.06,4.11,2015-01-22,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.09,4.05,2015-01-23,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.07,4.1,2015-01-26,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.09,4.04,2015-01-27,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.94,4.08,2015-01-28,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.92,3.91,2015-01-29,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.87,3.86,2015-01-30,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.81,3.86,2015-02-02,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.88,3.856,2015-02-03,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.93,3.83,2015-02-04,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.88,3.97,2015-02-05,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.02,3.95,2015-02-06,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.06,4.0,2015-02-09,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.06,4.11,2015-02-10,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.06,4.08,2015-02-11,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.07,4.06,2015-02-12,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.19,4.07,2015-02-13,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.39,4.29,2015-02-17,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.44,4.43,2015-02-18,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.58,4.47,2015-02-19,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.5,4.6,2015-02-20,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.46,4.48,2015-02-23,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.46,4.5,2015-02-24,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.45,4.49,2015-02-25,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.47,4.47,2015-02-26,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.4,4.49,2015-02-27,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.5,4.37,2015-03-02,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.52,4.5,2015-03-03,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.57,4.54,2015-03-04,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.5,4.59,2015-03-05,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.47,4.46,2015-03-06,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.47,4.56,2015-03-09,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.38,4.45,2015-03-10,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.4,4.38,2015-03-11,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.39,4.44,2015-03-12,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.3,4.41,2015-03-13,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.32,4.3,2015-03-16,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.36,4.31,2015-03-17,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.33,4.41,2015-03-18,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.35,4.3,2015-03-19,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.3,4.4,2015-03-20,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.35,4.3,2015-03-23,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.36,4.356,2015-03-24,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.15,4.36,2015-03-25,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.07,4.25,2015-03-26,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.03,4.1,2015-03-27,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.97,4.07,2015-03-30,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.95,3.95,2015-03-31,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.85,3.92,2015-04-01,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.85,3.84,2015-04-02,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.98,3.79,2015-04-06,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.02,4.01,2015-04-07,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.02,4.04,2015-04-08,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.1,4.05,2015-04-09,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.14,4.14,2015-04-10,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.2,4.17,2015-04-13,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.09,4.23,2015-04-14,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.07,4.07,2015-04-15,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.06,4.1,2015-04-16,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.99,4.02,2015-04-17,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.06,4.09,2015-04-20,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.0801,4.1,2015-04-21,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.04,4.1,2015-04-22,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.08,4.01,2015-04-23,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.16,4.1,2015-04-24,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.05,4.17,2015-04-27,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.07,4.069,2015-04-28,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.04,4.05,2015-04-29,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.96,4.05,2015-04-30,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.97,4.0,2015-05-01,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.06,3.97,2015-05-04,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.07,4.09,2015-05-05,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.39,4.06,2015-05-06,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.4,4.27,2015-05-07,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.93,4.34,2015-05-08,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.86,3.87,2015-05-11,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.95,4.02,2015-05-12,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.9,3.92,2015-05-13,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.04,3.9,2015-05-14,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.02,4.03,2015-05-15,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.99,3.98,2015-05-18,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.1,4.02,2015-05-19,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.03,4.14,2015-05-20,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.03,4.02,2015-05-21,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.01,4.01,2015-05-22,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.94,3.97,2015-05-26,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.88,3.98,2015-05-27,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.91,3.88,2015-05-28,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.93,3.89,2015-05-29,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.86,3.91,2015-06-01,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.85,3.833,2015-06-02,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.9,3.8,2015-06-03,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.87,3.92,2015-06-04,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.93,3.87,2015-06-05,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.93,3.94,2015-06-08,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.85,3.92,2015-06-09,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.85,3.909,2015-06-10,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.84,3.83,2015-06-11,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.83,3.88,2015-06-12,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.76,3.77,2015-06-15,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.76,3.76,2015-06-16,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.77,3.78,2015-06-17,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.02,3.88,2015-06-18,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.05,3.97,2015-06-19,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.03,4.04,2015-06-22,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.0,4.0,2015-06-23,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.0,4.02,2015-06-24,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.86,3.97,2015-06-25,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.81,3.8901,2015-06-26,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.67,3.83,2015-06-29,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.77,3.67,2015-06-30,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.8,3.79,2015-07-01,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.79,3.83,2015-07-02,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.77,3.77,2015-07-06,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.69,3.61,2015-07-07,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.49,3.7,2015-07-08,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.92,3.43,2015-07-09,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.08,3.9,2015-07-10,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.3,4.16,2015-07-13,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.47,4.44,2015-07-14,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.32,4.5,2015-07-15,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.28,4.35,2015-07-16,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.05,4.25,2015-07-17,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.05,4.04,2015-07-20,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.14,4.02,2015-07-21,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.11,4.1,2015-07-22,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.09,4.07,2015-07-23,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.07,4.08,2015-07-24,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.1,4.07,2015-07-27,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.12,4.09,2015-07-28,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.18,4.09,2015-07-29,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.06,4.25,2015-07-30,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.06,4.05,2015-07-31,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.05,4.03,2015-08-03,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.07,4.02,2015-08-04,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.05,4.086,2015-08-05,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.04,4.03,2015-08-06,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.03,4.04,2015-08-07,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.05,4.02,2015-08-10,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.07,4.06,2015-08-11,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.1,4.01,2015-08-12,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.1,4.12,2015-08-13,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.05,4.13,2015-08-14,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.06,4.05,2015-08-17,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.05,4.08,2015-08-18,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.08,4.03,2015-08-19,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.02,4.005,2015-08-20,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.99,3.98,2015-08-21,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.8,3.91,2015-08-24,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.73,3.89,2015-08-25,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.79,3.83,2015-08-26,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.77,3.79,2015-08-27,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.94,3.75,2015-08-28,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.75,3.86,2015-08-31,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.69,3.71,2015-09-01,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.69,3.73,2015-09-02,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.71,3.7,2015-09-03,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.71,3.69,2015-09-04,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.8,3.73,2015-09-08,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.82,3.83,2015-09-09,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.75,3.77,2015-09-10,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.83,3.75,2015-09-11,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.83,3.8,2015-09-14,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.97,3.84,2015-09-15,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.76,3.89,2015-09-16,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.92,3.79,2015-09-17,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.87,3.83,2015-09-18,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.75,3.86,2015-09-21,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.7,3.75,2015-09-22,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.68,3.72,2015-09-23,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.61,3.65,2015-09-24,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.51,3.6,2015-09-25,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.79,3.51,2015-09-28,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.56,3.56,2015-09-29,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.65,3.59,2015-09-30,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.59,3.64,2015-10-01,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.68,3.53,2015-10-02,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.82,3.71,2015-10-05,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.8,3.84,2015-10-06,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.72,3.8,2015-10-07,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.72,3.7,2015-10-08,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.79,3.72,2015-10-09,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.8,3.8,2015-10-12,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.74,3.79,2015-10-13,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.67,3.74,2015-10-14,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.83,3.92,2015-10-15,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.97,3.78,2015-10-16,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.94,3.98,2015-10-19,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.0,3.95,2015-10-20,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.88,3.98,2015-10-21,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.92,3.9,2015-10-22,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.87,3.94,2015-10-23,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.86,3.924,2015-10-26,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.75,3.85,2015-10-27,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.85,3.7389,2015-10-28,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.83,3.85,2015-10-29,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.84,3.72,2015-10-30,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.86,3.85,2015-11-02,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.84,3.81,2015-11-03,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.89,3.85,2015-11-04,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.93,3.89,2015-11-05,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.8,3.93,2015-11-06,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.87,3.78,2015-11-09,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.78,3.83,2015-11-10,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.77,3.81,2015-11-11,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.75,3.75,2015-11-12,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.75,3.71,2015-11-13,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.78,3.73,2015-11-16,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.75,3.75,2015-11-17,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.86,3.73,2015-11-18,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.81,3.85,2015-11-19,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.82,3.76,2015-11-20,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.75,3.78,2015-11-23,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.79,3.71,2015-11-24,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.9,3.76,2015-11-25,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.915,3.9,2015-11-27,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.88,3.9,2015-11-30,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.97,3.88,2015-12-01,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.9,3.94,2015-12-02,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.87,3.9,2015-12-03,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.895,3.86,2015-12-04,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.79,3.89,2015-12-07,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.89,3.74,2015-12-08,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.75,3.81,2015-12-09,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.72,3.75,2015-12-10,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.66,3.72,2015-12-11,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.51,3.66,2015-12-14,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.51,3.5,2015-12-15,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.78,3.53,2015-12-16,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.95,3.76,2015-12-17,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.69,3.92,2015-12-18,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.7,3.7,2015-12-21,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.49,5.5,2015-12-22,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.54,4.63,2015-12-23,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.37,4.48,2015-12-24,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.74,4.55,2015-12-28,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.67,4.66,2015-12-29,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.73,4.63,2015-12-30,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.82,4.74,2015-12-31,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.8,4.67,2016-01-04,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.48,4.79,2016-01-05,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.13,4.38,2016-01-06,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.33,4.18,2016-01-07,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.96,4.27,2016-01-08,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.91,4.06,2016-01-11,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.74,3.97,2016-01-12,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.55,3.75,2016-01-13,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.5,3.58,2016-01-14,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.46,3.45,2016-01-15,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.49,3.53,2016-01-19,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.65,3.43,2016-01-20,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.48,3.51,2016-01-21,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.57,3.53,2016-01-22,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.58,3.52,2016-01-25,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.72,3.58,2016-01-26,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.51,3.68,2016-01-27,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.45,3.51,2016-01-28,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.41,3.43,2016-01-29,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.51,3.37,2016-02-01,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.4,3.39,2016-02-02,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.34,3.38,2016-02-03,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.44,3.35,2016-02-04,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.38,3.44,2016-02-05,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.2,3.38,2016-02-08,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.04,3.15,2016-02-09,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.96,3.03,2016-02-10,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.82,2.95,2016-02-11,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.86,2.86,2016-02-12,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.81,2.86,2016-02-16,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.8,2.86,2016-02-17,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.9,2.78,2016-02-18,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.96,2.86,2016-02-19,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.8,2.95,2016-02-22,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.8,2.83,2016-02-23,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.78,2.75,2016-02-24,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.74,2.75,2016-02-25,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.77,2.73,2016-02-26,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.71,2.75,2016-02-29,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.75,2.71,2016-03-01,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.87,2.72,2016-03-02,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.79,2.88,2016-03-03,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.93,2.81,2016-03-04,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.13,2.94,2016-03-07,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.9,3.03,2016-03-08,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.88,2.88,2016-03-09,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.83,2.88,2016-03-10,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.91,2.83,2016-03-11,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.84,2.87,2016-03-14,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.7,2.8,2016-03-15,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.71,2.72,2016-03-16,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.5,2.69,2016-03-17,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.61,2.51,2016-03-18,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.66,2.63,2016-03-21,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.95,2.67,2016-03-22,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.69,2.92,2016-03-23,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.71,2.65,2016-03-24,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.67,2.71,2016-03-28,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.76,2.65,2016-03-29,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.64,2.77,2016-03-30,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.68,2.64,2016-03-31,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.79,2.64,2016-04-01,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.96,2.76,2016-04-04,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.0,2.97,2016-04-05,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.02,3.0,2016-04-06,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.99,3.04,2016-04-07,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.95,2.99,2016-04-08,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.81,2.94,2016-04-11,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.89,2.86,2016-04-12,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.87,2.89,2016-04-13,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.02,2.9,2016-04-14,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.96,2.98,2016-04-15,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.06,2.92,2016-04-18,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.25,3.08,2016-04-19,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.104,3.22,2016-04-20,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.24,3.18,2016-04-21,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.15,3.28,2016-04-22,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.17,3.2,2016-04-25,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.02,3.17,2016-04-26,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.02,2.98,2016-04-27,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.02,3.03,2016-04-28,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.87,3.035,2016-04-29,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.94,2.97,2016-05-02,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.99,2.95,2016-05-03,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.85,2.95,2016-05-04,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.86,2.87,2016-05-05,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.87,2.72,2016-05-06,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.99,2.87,2016-05-09,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.97,3.0,2016-05-10,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.96,2.93,2016-05-11,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.79,2.91,2016-05-12,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.75,2.8,2016-05-13,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.77,2.75,2016-05-16,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.77,2.76,2016-05-17,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.83,2.75,2016-05-18,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.81,2.84,2016-05-19,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.86,2.79,2016-05-20,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.95,2.85,2016-05-23,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.04,2.97,2016-05-24,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.0,3.011,2016-05-25,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.1,2.98,2016-05-26,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.85,3.06,2016-05-27,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.5,3.84,2016-05-31,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.52,3.5,2016-06-01,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.64,3.46,2016-06-02,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.51,3.64,2016-06-03,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.43,3.47,2016-06-06,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.46,3.4,2016-06-07,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.56,3.46,2016-06-08,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.43,3.585,2016-06-09,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.49,3.419,2016-06-10,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.43,3.51,2016-06-13,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.28,3.4,2016-06-14,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.26,3.33,2016-06-15,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.06,3.25,2016-06-16,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.0,3.1,2016-06-17,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.05,2.94,2016-06-20,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.01,3.27,2016-06-21,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.94,3.12,2016-06-22,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.2,2.99,2016-06-23,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.08,3.1,2016-06-24,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.81,3.03,2016-06-27,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.84,2.86,2016-06-28,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.83,2.89,2016-06-29,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.83,2.82,2016-06-30,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.95,2.85,2016-07-01,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.06,3.01,2016-07-05,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.02,3.04,2016-07-06,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.0668,3.0649,2016-07-07,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.15,3.08,2016-07-08,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.2,3.15,2016-07-11,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.3,3.2,2016-07-12,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.26,3.3,2016-07-13,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.5,3.25,2016-07-14,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.43,3.48,2016-07-15,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.31,3.38,2016-07-18,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.33,3.34,2016-07-19,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.5,3.36,2016-07-20,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.49,3.53,2016-07-21,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.49,3.47,2016-07-22,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.36,3.48,2016-07-25,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.78,3.33,2016-07-26,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.79,3.85,2016-07-27,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.81,3.78,2016-07-28,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.82,3.768,2016-07-29,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.93,3.8,2016-08-01,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.91,3.93,2016-08-02,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.93,3.88,2016-08-03,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.91,3.94,2016-08-04,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.94,3.902,2016-08-05,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.92,3.97,2016-08-08,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.0,3.91,2016-08-09,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.91,3.98,2016-08-10,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.92,3.93,2016-08-11,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.93,3.904,2016-08-12,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.11,4.0,2016-08-15,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.08,4.13,2016-08-16,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.0,4.06,2016-08-17,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.99,4.03,2016-08-18,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.96,4.01,2016-08-19,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.02,3.92,2016-08-22,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,4.0,4.0,2016-08-23,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.98,4.0,2016-08-24,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.96,3.9972,2016-08-25,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.93,3.97,2016-08-26,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.98,3.92,2016-08-29,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.97,3.96,2016-08-30,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.87,3.97,2016-08-31,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.77,3.85,2016-09-01,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.7,3.75,2016-09-02,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.7,3.7,2016-09-06,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.68,3.72,2016-09-07,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.7101,3.71,2016-09-08,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.7,3.72,2016-09-09,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.83,3.7,2016-09-12,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.76,3.79,2016-09-13,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.72,3.73,2016-09-14,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.63,3.7,2016-09-15,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.55,3.62,2016-09-16,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.47,3.52,2016-09-19,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.465,3.47,2016-09-20,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.39,3.46,2016-09-21,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.28,3.35,2016-09-22,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.22,3.27,2016-09-23,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.17,3.19,2016-09-26,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.23,3.12,2016-09-27,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.25,3.25,2016-09-28,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.18,3.26,2016-09-29,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.01,3.17,2016-09-30,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.94,3.0,2016-10-03,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.83,2.97,2016-10-04,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.94,2.81,2016-10-05,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.8,2.91,2016-10-06,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.69,2.76,2016-10-07,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.39,2.66,2016-10-10,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.41,2.39,2016-10-11,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.38,2.4,2016-10-12,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.35,2.37,2016-10-13,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.31,2.33,2016-10-14,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.28,2.29,2016-10-17,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.33,2.28,2016-10-18,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.28,2.32,2016-10-19,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.28,2.27,2016-10-20,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.33,2.28,2016-10-21,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.31,2.35,2016-10-24,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.19,2.32,2016-10-25,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.17,2.19,2016-10-26,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.14,2.17,2016-10-27,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.11,2.14,2016-10-28,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.08,2.09,2016-10-31,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.96,2.08,2016-11-01,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.91,1.96,2016-11-02,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.91,1.93,2016-11-03,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.96,1.92,2016-11-04,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.07,1.98,2016-11-07,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.98,2.08,2016-11-08,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.93,1.95,2016-11-09,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.96,1.97,2016-11-10,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.92,1.96,2016-11-11,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.91,1.93,2016-11-14,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.87,1.92,2016-11-15,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.93,1.87,2016-11-16,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.91,1.97,2016-11-17,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.88,1.92,2016-11-18,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.94,1.88,2016-11-21,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.9,1.943,2016-11-22,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.85,1.9,2016-11-23,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.84,1.85,2016-11-25,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.89,1.85,2016-11-28,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.91,1.89,2016-11-29,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.86,1.93,2016-11-30,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.77,1.82,2016-12-01,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.81,1.77,2016-12-02,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.72,1.8,2016-12-05,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.72,1.72,2016-12-06,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.74,1.73,2016-12-07,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.69,1.72,2016-12-08,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.74,1.69,2016-12-09,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.7,1.75,2016-12-12,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.56,1.7,2016-12-13,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.56,1.56,2016-12-14,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.6,1.58,2016-12-15,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.73,1.66,2016-12-16,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.81,1.73,2016-12-19,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.88,1.85,2016-12-20,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.85,1.89,2016-12-21,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.84,1.83,2016-12-22,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.97,1.84,2016-12-23,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.94,1.95,2016-12-27,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.8,1.94,2016-12-28,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.68,1.81,2016-12-29,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.71,1.7,2016-12-30,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.77,1.73,2017-01-03,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.84,1.83,2017-01-04,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.9,1.85,2017-01-05,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.9,1.9,2017-01-06,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.89,1.9,2017-01-09,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.09,1.9,2017-01-10,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.97,2.09,2017-01-11,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.94,1.95,2017-01-12,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.94,1.91,2017-01-13,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.91,1.92,2017-01-17,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.82,1.92,2017-01-18,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.85,1.849,2017-01-19,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.83,1.81,2017-01-20,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.82,1.82,2017-01-23,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.81,1.82,2017-01-24,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.82,1.83,2017-01-25,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.79,1.82,2017-01-26,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.79,1.8,2017-01-27,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.75,1.77,2017-01-30,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.76,1.73,2017-01-31,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.76,1.73,2017-02-01,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.75,1.79,2017-02-02,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.71,1.71,2017-02-03,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.69,1.727,2017-02-06,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.66,1.71,2017-02-07,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.76,1.81,2017-02-08,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.86,1.77,2017-02-09,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.78,1.85,2017-02-10,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.74,1.75,2017-02-13,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.7,1.73,2017-02-14,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.75,1.71,2017-02-15,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.76,1.76,2017-02-16,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.8,1.76,2017-02-17,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.8,1.78,2017-02-21,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.82,1.8,2017-02-22,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.75,1.82,2017-02-23,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.78,1.751,2017-02-24,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.78,1.76,2017-02-27,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.75,1.78,2017-02-28,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.77,1.76,2017-03-01,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.76,1.76,2017-03-02,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.71,1.74,2017-03-03,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.71,1.75,2017-03-06,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.71,1.71,2017-03-07,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.7,1.69,2017-03-08,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.69,1.7,2017-03-09,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.7,1.7,2017-03-10,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.7,1.7,2017-03-13,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.675,1.705,2017-03-14,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.7,1.7,2017-03-15,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.69,1.735,2017-03-16,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.7,1.69,2017-03-17,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.71,1.7,2017-03-20,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.7,1.74,2017-03-21,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.68,1.69,2017-03-22,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.7,1.67,2017-03-23,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.6999,1.7,2017-03-24,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.72,1.68,2017-03-27,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.8,1.7,2017-03-28,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.85,1.8,2017-03-29,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.75,1.86,2017-03-30,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.72,1.75,2017-03-31,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.69,1.71,2017-04-03,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.69,1.69,2017-04-04,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.63,1.7,2017-04-05,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.72,1.65,2017-04-06,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.66,1.73,2017-04-07,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.7701,1.65,2017-04-10,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.71,1.79,2017-04-11,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.68,1.72,2017-04-12,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.69,1.68,2017-04-13,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.71,1.71,2017-04-17,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.74,1.74,2017-04-18,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.74,1.74,2017-04-19,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.77,1.75,2017-04-20,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.77,1.79,2017-04-21,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.77,1.78,2017-04-24,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.73,1.78,2017-04-25,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.735,1.73,2017-04-26,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.72,1.75,2017-04-27,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.72,1.73,2017-04-28,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.7,1.72,2017-05-01,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.71,1.72,2017-05-02,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.69,1.7,2017-05-03,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.68,1.69,2017-05-04,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.97,1.76,2017-05-05,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.94,2.05,2017-05-08,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.99,1.94,2017-05-09,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.04,1.98,2017-05-10,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.02,2.06,2017-05-11,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.08,2.02,2017-05-12,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.08,2.09,2017-05-15,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.04,2.08,2017-05-16,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.08,2.03,2017-05-17,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.13,2.08,2017-05-18,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.24,2.14,2017-05-19,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.21,2.26,2017-05-22,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.16,2.2,2017-05-23,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.14,2.17,2017-05-24,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.13,2.12,2017-05-25,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.22,2.14,2017-05-26,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.32,2.3,2017-05-30,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.27,2.33,2017-05-31,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.27,2.32,2017-06-01,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.25,2.28,2017-06-02,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.2,2.25,2017-06-05,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.14,2.2,2017-06-06,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.15,2.15,2017-06-07,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.14,2.15,2017-06-08,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.09,2.13,2017-06-09,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.08,2.09,2017-06-12,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.75,1.91,2017-06-13,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.75,1.79,2017-06-14,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.73,1.82,2017-06-15,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.85,1.77,2017-06-16,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.84,1.89,2017-06-19,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.83,1.83,2017-06-20,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.85,1.85,2017-06-21,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.82,1.84,2017-06-22,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.91,1.82,2017-06-23,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.83,1.92,2017-06-26,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.77,1.83,2017-06-27,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.77,1.79,2017-06-28,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.7,1.78,2017-06-29,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.71,1.72,2017-06-30,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.76,1.73,2017-07-03,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.71,1.76,2017-07-05,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.71,1.72,2017-07-06,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.76,1.71,2017-07-07,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.66,1.73,2017-07-10,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.38,1.63,2017-07-11,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.41,1.38,2017-07-12,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.39,1.42,2017-07-13,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.51,1.39,2017-07-14,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.44,1.52,2017-07-17,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.41,1.45,2017-07-18,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.38,1.42,2017-07-19,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.39,1.38,2017-07-20,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.37,1.38,2017-07-21,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.35,1.4,2017-07-24,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.32,1.34,2017-07-25,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.28,1.33,2017-07-26,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.23,1.27,2017-07-27,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.2,1.25,2017-07-28,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.23,1.2,2017-07-31,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.17,1.25,2017-08-01,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.15,1.19,2017-08-02,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.16,1.16,2017-08-03,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.2,1.17,2017-08-04,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.16,1.2,2017-08-07,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.21,1.16,2017-08-08,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.18,1.21,2017-08-09,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.12,1.18,2017-08-10,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.11,1.11,2017-08-11,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.11,1.12,2017-08-14,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.08,1.114,2017-08-15,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.08,1.09,2017-08-16,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.06,1.06,2017-08-17,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.07,1.05,2017-08-18,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.14,1.06,2017-08-21,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.12,1.15,2017-08-22,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.17,1.13,2017-08-23,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.17,1.15,2017-08-24,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.24,1.19,2017-08-25,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.21,1.25,2017-08-28,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.17,1.2,2017-08-29,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.21,1.16,2017-08-30,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.21,1.23,2017-08-31,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.27,1.23,2017-09-01,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.24,1.25,2017-09-05,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.27,1.23,2017-09-06,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.3,1.27,2017-09-07,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.28,1.28,2017-09-08,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.37,1.28,2017-09-11,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.3,1.36,2017-09-12,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.26,1.29,2017-09-13,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.22,1.27,2017-09-14,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.21,1.23,2017-09-15,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.28,1.26,2017-09-18,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.25,1.29,2017-09-19,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.25,1.27,2017-09-20,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.22,1.22,2017-09-21,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.25,1.24,2017-09-22,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.25,1.27,2017-09-25,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.24,1.29,2017-09-26,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.195,1.24,2017-09-27,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.195,1.21,2017-09-28,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.2,1.18,2017-09-29,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.195,1.21,2017-10-02,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.195,1.2,2017-10-03,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.19,1.19,2017-10-04,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.26,1.2,2017-10-05,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.23,1.29,2017-10-06,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.22,1.25,2017-10-09,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.24,1.32,2017-10-10,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.24,1.23,2017-10-11,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.22,1.25,2017-10-12,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.23,1.22,2017-10-13,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.21,1.25,2017-10-16,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.2,1.22,2017-10-17,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.2,1.19,2017-10-18,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.2,1.2,2017-10-19,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.2,1.2,2017-10-20,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.2,1.2,2017-10-23,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.2,1.22,2017-10-24,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.2,1.21,2017-10-25,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.19,1.2,2017-10-26,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.19,1.2,2017-10-27,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.16,1.19,2017-10-30,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.17,1.17,2017-10-31,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.1799,1.17,2017-11-01,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.19,1.18,2017-11-02,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.23,1.2,2017-11-03,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.26,1.25,2017-11-06,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.16,1.17,2017-11-07,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.23,1.2,2017-11-08,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.34,1.25,2017-11-09,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.38,1.35,2017-11-10,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.28,1.4,2017-11-13,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.22,1.26,2017-11-14,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.21,1.2,2017-11-15,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.22,1.21,2017-11-16,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.26,1.24,2017-11-17,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.27,1.27,2017-11-20,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.31,1.27,2017-11-21,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.33,1.34,2017-11-22,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.33,1.33,2017-11-24,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.27,1.29,2017-11-27,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.26,1.26,2017-11-28,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.25,1.28,2017-11-29,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.26,1.25,2017-11-30,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.28,1.25,2017-12-01,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.31,1.28,2017-12-04,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.27,1.31,2017-12-05,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.24,1.26,2017-12-06,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.27,1.22,2017-12-07,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.23,1.27,2017-12-08,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.18,1.23,2017-12-11,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.19,1.18,2017-12-12,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.15,1.18,2017-12-13,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.06,1.2,2017-12-14,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.13,1.07,2017-12-15,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.08,1.16,2017-12-18,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.06,1.08,2017-12-19,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.05,1.07,2017-12-20,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.05,1.07,2017-12-21,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.045,1.05,2017-12-22,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.03,1.02,2017-12-26,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.07,1.04,2017-12-27,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.05,1.08,2017-12-28,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.08,1.06,2017-12-29,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.11,1.1,2018-01-02,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.12,1.12,2018-01-03,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.13,1.14,2018-01-04,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.12,1.11,2018-01-05,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.1,1.13,2018-01-08,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.1,1.1,2018-01-09,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.06,1.11,2018-01-10,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.11,1.05,2018-01-11,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.14,1.13,2018-01-12,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.1,1.15,2018-01-16,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.08,1.09,2018-01-17,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.09,1.08,2018-01-18,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.11,1.09,2018-01-19,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.1,1.12,2018-01-22,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.09,1.1,2018-01-23,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.12,1.1,2018-01-24,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.31,1.16,2018-01-25,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.27,1.27,2018-01-26,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.24,1.27,2018-01-29,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.2,1.24,2018-01-30,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.14,1.19,2018-01-31,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.11,1.12,2018-02-01,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.1,1.11,2018-02-02,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.05,1.1,2018-02-05,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.1,1.01,2018-02-06,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.06,1.1,2018-02-07,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.07,1.1,2018-02-08,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.04,1.09,2018-02-09,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.04,1.04,2018-02-12,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.06,1.04,2018-02-13,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.07,1.05,2018-02-14,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.09,1.07,2018-02-15,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.1,1.09,2018-02-16,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.09,1.08,2018-02-20,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.09,1.1,2018-02-21,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.09,1.1,2018-02-22,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.09,1.09,2018-02-23,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.07,1.1,2018-02-26,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.09,1.06,2018-02-27,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.05,1.09,2018-02-28,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.06,1.05,2018-03-01,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.09,1.08,2018-03-02,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.105,1.09,2018-03-05,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.17,1.12,2018-03-06,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.21,1.2,2018-03-07,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.23,1.21,2018-03-08,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.24,1.25,2018-03-09,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.2,1.25,2018-03-12,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.195,1.19,2018-03-13,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.19,1.2,2018-03-14,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.23,1.21,2018-03-15,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.23,1.24,2018-03-16,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.16,1.21,2018-03-19,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.16,1.17,2018-03-20,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.2,1.15,2018-03-21,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.25,1.2,2018-03-22,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.19,1.25,2018-03-23,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.15,1.21,2018-03-26,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.11,1.15,2018-03-27,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.07,1.1,2018-03-28,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.22,1.33,2018-03-29,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.15,1.2,2018-04-02,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.14,1.15,2018-04-03,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.19,1.17,2018-04-04,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.18,1.2,2018-04-05,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.17,1.16,2018-04-06,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.16,1.17,2018-04-09,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.14,1.16,2018-04-10,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.26,1.15,2018-04-11,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.46,1.28,2018-04-12,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.44,1.46,2018-04-13,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.35,1.45,2018-04-16,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.44,1.39,2018-04-17,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.52,1.47,2018-04-18,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.75,1.55,2018-04-19,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.73,1.75,2018-04-20,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.65,1.73,2018-04-23,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.99,1.68,2018-04-24,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.37,2.0,2018-04-25,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.47,2.21,2018-04-26,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.29,2.46,2018-04-27,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.46,2.23,2018-04-30,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.69,2.47,2018-05-01,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.7,2.73,2018-05-02,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.61,2.7,2018-05-03,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.44,2.54,2018-05-04,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.39,2.37,2018-05-07,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.33,2.35,2018-05-08,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.55,2.3,2018-05-09,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.0,2.55,2018-05-10,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.01,2.05,2018-05-11,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.95,1.98,2018-05-14,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.03,1.92,2018-05-15,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.05,2.03,2018-05-16,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.18,2.05,2018-05-17,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.11,2.19,2018-05-18,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.02,2.13,2018-05-21,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.98,2.02,2018-05-22,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.95,1.98,2018-05-23,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.07,1.95,2018-05-24,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.01,2.08,2018-05-25,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.16,2.0,2018-05-29,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.18,2.18,2018-05-30,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.17,2.18,2018-05-31,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.28,2.2,2018-06-01,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.25,2.24,2018-06-04,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.295,2.25,2018-06-05,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.37,2.31,2018-06-06,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.275,2.37,2018-06-07,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.22,2.26,2018-06-08,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.21,2.22,2018-06-11,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.09,2.2,2018-06-12,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.05,2.11,2018-06-13,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.04,2.06,2018-06-14,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.04,2.01,2018-06-15,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.01,2.02,2018-06-18,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.02,2.0,2018-06-19,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.99,2.08,2018-06-20,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.95,2.0,2018-06-21,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.0,1.95,2018-06-22,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.93,2.0,2018-06-25,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.87,1.93,2018-06-26,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.86,1.85,2018-06-27,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.85,1.84,2018-06-28,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.08,1.85,2018-06-29,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.09,2.1,2018-07-02,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.11,2.1,2018-07-03,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.16,2.13,2018-07-05,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.18,2.15,2018-07-06,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.27,2.18,2018-07-09,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.26,2.3,2018-07-10,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.22,2.26,2018-07-11,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.2,2.23,2018-07-12,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.15,2.22,2018-07-13,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.11,2.14,2018-07-16,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.12,2.12,2018-07-17,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.12,2.1,2018-07-18,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.48,2.13,2018-07-19,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.44,2.48,2018-07-20,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.32,2.44,2018-07-23,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.26,2.31,2018-07-24,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.44,2.25,2018-07-25,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.36,2.47,2018-07-26,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.3,2.36,2018-07-27,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.26,2.29,2018-07-30,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.27,2.25,2018-07-31,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.22,2.3,2018-08-01,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.21,2.25,2018-08-02,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.13,2.22,2018-08-03,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.11,2.11,2018-08-06,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.14,2.15,2018-08-07,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.15,2.15,2018-08-08,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.15,2.14,2018-08-09,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.2,2.18,2018-08-10,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.14,2.22,2018-08-13,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.1,2.14,2018-08-14,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.05,2.09,2018-08-15,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.06,2.07,2018-08-16,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.99,2.04,2018-08-17,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.95,2.0,2018-08-20,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.03,2.0,2018-08-21,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.05,2.04,2018-08-22,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.02,2.02,2018-08-23,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.07,2.04,2018-08-24,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.08,2.09,2018-08-27,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.09,2.1,2018-08-28,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.12,2.09,2018-08-29,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.18,2.12,2018-08-30,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.19,2.14,2018-08-31,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.21,2.21,2018-09-04,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.12,2.2,2018-09-05,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.32,2.33,2018-09-06,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.22,2.32,2018-09-07,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.22,2.23,2018-09-10,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.29,2.2,2018-09-11,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.28,2.23,2018-09-12,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.21,2.32,2018-09-13,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.2,2.21,2018-09-14,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.34,2.22,2018-09-17,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.4,2.33,2018-09-18,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.5,2.38,2018-09-19,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.5,2.5,2018-09-20,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.6,2.47,2018-09-21,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.69,2.63,2018-09-24,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.12,2.74,2018-09-25,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.35,3.15,2018-09-26,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.76,3.38,2018-09-27,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.57,3.76,2018-09-28,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.53,3.7,2018-10-01,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.51,3.55,2018-10-02,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.77,3.51,2018-10-03,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.7,3.83,2018-10-04,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.37,3.7,2018-10-05,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.28,3.35,2018-10-08,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.36,3.3,2018-10-09,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.22,3.38,2018-10-10,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.06,3.22,2018-10-11,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.23,3.14,2018-10-12,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.45,3.3,2018-10-15,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,3.18,3.5,2018-10-16,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.99,3.22,2018-10-17,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.95,2.97,2018-10-18,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.65,2.94,2018-10-19,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.44,2.64,2018-10-22,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.39,2.38,2018-10-23,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.23,2.4,2018-10-24,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.27,2.23,2018-10-25,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.22,2.23,2018-10-26,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.0,2.22,2018-10-29,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.14,2.06,2018-10-30,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.14,2.12,2018-10-31,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.36,2.16,2018-11-01,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.47,2.34,2018-11-02,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.31,2.51,2018-11-05,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.32,2.3,2018-11-06,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.35,2.3,2018-11-07,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.36,2.28,2018-11-08,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.3,2.35,2018-11-09,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.15,2.29,2018-11-12,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.03,2.17,2018-11-13,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.05,2.08,2018-11-14,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.08,2.05,2018-11-15,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.17,2.08,2018-11-16,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.12,2.17,2018-11-19,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.07,2.06,2018-11-20,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.21,2.1,2018-11-21,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.23,2.18,2018-11-23,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.07,2.24,2018-11-26,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.06,2.06,2018-11-27,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.06,2.08,2018-11-28,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.26,2.06,2018-11-29,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.36,2.27,2018-11-30,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.3,2.4,2018-12-03,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.22,2.3,2018-12-04,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.18,2.15,2018-12-06,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.2,2.21,2018-12-07,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.25,2.2,2018-12-10,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.19,2.25,2018-12-11,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.33,2.22,2018-12-12,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.32,2.33,2018-12-13,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.26,2.29,2018-12-14,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.31,2.26,2018-12-17,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.22,2.35,2018-12-18,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,2.1,2.22,2018-12-19,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.86,2.08,2018-12-20,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.65,1.95,2018-12-21,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.5,1.65,2018-12-24,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.73,1.54,2018-12-26,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.75,1.73,2018-12-27,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.78,1.73,2018-12-28,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
30233G20,1.89,1.78,2018-12-31,EYPT,EYEPOINT PHARMACEUTICALS INC,2834.0,160.0
